ONTX

Onconova Therapeutics Inc (ONTX) | Rumor.io

Onconova Therapeutics

ONTX

Attention (50-day avg)0%

Attention rank (50-day avg)#4,734

Bullish sentiment (50-day avg)100%

Price to earnings ratio-17.7

Market capitalization336.7M

Earnings per share-0.9

Dividend yield (TTM)—

Revenue (annual)226K

Net income (annual)-18.9M

Social

What share of all stock conversation is about ONTX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Apr 2

Onconova Therapeutics, Inc. ($ONTX) has announced a business combination with Trawsfynydd Therapeutics to form Traws Pharma, Inc, a best-in-class virology and oncology company.
The combined entity will have a low float of approximately 21 million shares and a pre-market price of $0.96.
Onconova Therapeutics' stock is down -6.00% in the pre-market trading session, with a current price of $1.12.

Generated by AI

Sentiment

Of the messages about ONTX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	25% -75
Bearish	—	—	—	75% new

Bullish· Sep 22

$ONTX is showing encouraging clinical data from a lung-cancer treatment trial, leading to significant price movements and potential for further growth.
Onconova Therapeutics has demonstrated strong resilience, bouncing back from mid-5's to 6.20 and showing no signs of weakness, with some analysts predicting a potential price increase to $10+.
The stock is building strength, with a clear path to new highs if it can break above key resistance areas, particularly around $6.55 and $6.69.

Bearish· Mar 4

Onconova Therapeutics' stock price has been heavily affected by the market crash, with a significant drop in value.
The company's stock has been sold off heavily, with the author adding to their position at a low price, indicating a potential buying opportunity.
The author has set stop losses on their Onconova Therapeutics and Itramarc holdings, indicating a risk management strategy to limit potential losses.

Generated by AI

Topics

Of the messages about ONTX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Announcements· Apr 21

Onconova Therapeutics, Inc. ($ONTX) upgraded to Buy from Neutral at H.C. Wainwright.
No further announcements were made about $ONTX.
No other information was provided about the upgrade or its implications.

Technical Analysis· Mar 1

ONTX is considered a catalyst stock due to its pipeline, insider buys, and large social media following, with volume expected to increase.
ONTX is holding within its support and resistance zone, with 20EMA acting as support, and is expected to see a nice pop once volume increases.
ONTX has a low risk entry point, with a potential reward of 1.8-2.5, but requires a breakdown of the 1.20 level and retest of 1.60.

Generated by AI

Community

Of the messages about ONTX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	34%
Newcomers	—	—	0%	66%

Regulars· Apr 21

$ONTX is being considered for a potential continuation play, with the closest round number at 1 and trending with 11.2% already.
Regulars are discussing the float rotation on $ONTX, which has already traded one rotation, with a gain of 36.0% and a short float of 0.1%.
The Aroon Indicator on $ONTX has entered a downtrend, indicating a possible reversal in the stock's momentum.

Newcomers· Dec 11

New traders are focusing on the potential for Onconova Therapeutics to reach $0.88, which could lead to more gains.
Some newcomers are taking positions in Onconova Therapeutics, with one trader setting a stop-loss under $0.78 or $0.77.
Traders are monitoring Onconova Therapeutics for a potential break above $0.88, with one user noting a sharp pullback from Friday's extended hours move.

Generated by AI

Also Discussed

Investors talking about ONTX also mention

#	Name	Attention
1	GHSI - Guardion Health Sciences, Inc.	——
2	Oragenics Inc.OGEN	0%0
3	InpixonINPX	0%0
4	BIOL - BIOLASE, Inc.	——
5	iBio, Inc.IBIO	0%0
6	Grace Therapeutics Inc.ACST	0%0
7	InspireMD, Inc.NSPR	0%new
8	Tonix Pharmaceuticals Holding CorpTNXP	0.01%-0.18
9	ZOM - Zomedica Corp.	——
10	TTNP - Titan Pharmaceuticals, Inc.	——